The effect of cigarette or sheesha smoking on first-trimester markers of Down syndrome

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 114, Issue 11, 2007, Pages 1397-1401

  Ardawi, M S M ^a,b   Nasrat, H A ^b   Rouzi, A A ^b   Qari, M H ^b   Al Qahtani, M H ^a,b   Abuzenadah, A M ^b  

^a KING ABDUL AZIZ UNIVERSITY HOSPITAL   (Saudi Arabia)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Cigarette; Fetal NT; First trimester; Free hCG; PAPP A; Sheesha; Smoking

Indexed keywords

BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT; COTININE; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE MARKER; DOWN SYNDROME; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; HORMONE BLOOD LEVEL; HUMAN; MATERNAL BLOOD; NORMAL HUMAN; NUCHAL TRANSLUCENCY MEASUREMENT; OBSERVATIONAL STUDY; PREGNANCY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SCREENING TEST; SHEESHA SMOKING; SMOKING;

ADULT; BIOLOGICAL MARKERS; BIRTH WEIGHT; CHORIONIC GONADOTROPIN; COTININE; CROWN-RUMP LENGTH; DOWN SYNDROME; FEMALE; HUMANS; MALE; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROSPECTIVE STUDIES; SAUDI ARABIA; SEX DISTRIBUTION; SMOKING;

EID: 35348981225     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2007.01448.x     Document Type: Article

References (32)

1. Orlandi F, Damiani G, Hallahan TW, Krantz DA, Macri JN. First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency. Ultrasound Obstet Gynecol 1997 10 : 381 6.
2. de Biasio P, Siccardi M, Volpe G, Famularo L, Santi F, Canini S. First-trimester screening for Down syndrome using nuchal translucency measurement with free [beta]-hCG and PAPP-A between 10 and 13 weeks of pregnancy - the combined test. Prenat Diagn 1999 19 : 360 3.
3. Bindra R, Heath V, Liao A, Spencer K, Nicolaides KH. One-stop clinic for assessment of risk of trisomy 21 at 11-14 weeks: a prospective study of 15,030 pregnancies. Ultrasound Obstet Gynecol 2002 20 : 219 25.
4. Crossley JA, Aitken DA, Cameron AD, McBride E, Connor JM. Combined ultrasound and biochemical screening for Down's syndrome in the first trimester; a Scottish multicenter study. BJOG 2002 109 : 667 76.
5. Wapner R, Thom E, Simpson JL, Pergament E, Silver R, Filkins K, et al. First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. First-trimester screening for trisomies 21 and 18. N Engl J Med 2002 349 : 1405 13.
6. Spencer K, Bindra R, Nicolaides KH. Maternal weight correction of maternal serum PAPP-A and free β-hCG MoM when screening for trisomy 21 in the first trimester of pregnancy. Prenat Diagn 2003 23 : 851 5.
7. Spencer K, Spencer CE, Power M, Moakes A, Nicolaides KH. One-stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester. BJOG 2000 107 : 1271 5.
8. O'Leary P, Breheny N, Dickinson JE, Bower C, Goldblatt J, Hewitt B, et al. First-trimester combined screening for Down syndrome and other fetal anomalies. Obstet Gynecol 2006 107 : 869 76.
9. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First- and Second-trimester Evaluation of Risk (FASTER) Research Consortium. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005 353 : 2001 11.
10. Bartels I, Hoppe-Sievert B, Bockel B, Herold S, Caesar J. Adjustment formulae for maternal serum alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol to maternal weight and smoking. Prenat Diagn 1993 13 : 123 30.
11. Cuckle HS, Wald NJ, Densem JW, Royston P, Knight GJ, Haddow JE, et al. The effect of smoking in pregnancy on maternal serum alpha-fetoprotein, unconjugated oestriol, human chorionic gonadotrophin, progesterone and dehydroepiandrosterone sulphate levels. Br J Obstet Gynaecol 1990 97 : 272 4.
12. Palomaki GE, Knight GJ, Haddow JE, Canick JA, Wald NJ, Kennard A. Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: impact on screening for Down syndrome. Obstet Gynaecol 1993 81 : 675 8.
13. Bernstein L, Pike MC, Lobo RA, Depue RH, Ross RK, Henderson BE. Cigarette smoking in pregnancy results in marked decrease in maternal hCG and oestradiol levels. Br J Obstet Gynaecol 1989 96 : 92 6.
14. Niemimaa M, Suonpaa M, Perheentupa A, Seppala M, Heinonen S, Laitinen P, et al. Evaluation of first trimester maternal serum and ultrasound screening for Down's syndrome in Eastern and Northern Finland. Eur J Hum Genet 2001 9 : 404 8.
15. Spencer K. The influence of smoking on maternal serum PAPP-A and free beta hCG levels in the first trimester of pregnancy. Prenat Diagn 1999 19 : 1065 6.
16. Spencer K, Ong CYT, Liao AWJ, Papademetriou D, Nicolaides KH. First trimester markers of trisomy 21 and the influence of maternal cigarette smoking status. Prenat Diagn 2000 20 : 852 3.
17. Spencer K, Bindra R, Cacho AM, Nicolaides KH. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy. Prenat Diagn 2004 24 : 169 73.
18. de Graaf IM, Cuckle HS, Pajkrt E, Leschot NJ, Bleker OP, van Lith JMM. Co-variables in first trimester maternal serum screening. Prenat Diagn 2000 20 : 186 9.
19. Yigiter AB, Kavak ZN, Bakirci N, Gokaslan H. Effect of smoking on pregnancy-associated plasma protein A, free β-human chorionic gonadotrophin, and nuchal translucency in the first trimester of pregnancy. Adv Ther 2006 23 : 131 8.
20. Zahran FM, Ardawi MS, Al-Fayez SF. Carboxyhaemoglobin concentration in smokers of sheesha and cigarette in Saudi Arabian. Br Med J (Clin Res Ed) 1985 291 : 1768 70.
21. Snijders RJM, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicenter project on assessment of risk trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998 352 : 343 6.
22. SRNT Subcommittee on Biochemical Verification 2002. Biochemical verification of tobacco use and cessation. Nicotine Tob Res 2002 4 : 149 59.
23. Neveux LM, Palomaki GE, Larrivee DA, Knight GJ, Haddow JE. Refinements in managing maternal weight adjustment for interpreting prenatal screening results. Prenat Diagn 1996 16 : 1115 19.
24. Saeed AA, Khoja TA, Khan SB. Smoking behaviour and attitudes among adult Saudi nationals in Riyadh City, Saudi Arabia. Tob Control 1996 5 : 215 19.
25. Jarallah JS, Al-Rubeaan KA, Al-Nuaim AR, Al-Ruhaily AA, Kalantan KA. Prevalence and determinants of smoking in three regions of Saudi Arabia. Tob Control 1999 8 : 53 6.
26. Shawky S, Abalkhail BA. Maternal factors associated with the duration of breast feeding in Jeddah, Saudi Arabia. Paediatr Perinat Epidemiol 2003 17 : 91 6.
27. Binnie V, McHugh S, Macpherson L, Borland B, Moir K, Malik K. The validation of self-reported smoking status by analyzing of cotinine levels in stimulated and unstimulated saliva, serum and urine. Oral Dis 2004 10 : 287 93.
28. Eskenazi B, Bergmann JJ. Passive and active maternal smoking during pregnancy, as measured by serum cotinine, and postnatal smoke exposure. I. Effects on physical growth at age 5 years. Am J Epidemiol 1995 142 : S10 18.
29. Greco P, Loverro G, Vimercati A, Marzullo A, Caruso G, Selvaggi L. Pathological significance of first trimester fetal nuchal oedema. Prenat Diagn 1996 16 : 503 9.
30. Demir R, Demir AY, Yinanc M. Structural changes in placental barrier of smoking mother: a quantitative and ultrastructural study. Pathol Res Pract 1994 190 : 656 67.
31. Marana HR, Andrade JM, Martins GA, Silva JS, Sala MA, Cunha SP. A morphometric study of maternal smoking on apoptosis in the syncytiotrophoblast. Int J Gynaecol Obstet 1998 61 : 21 7.
32. Jauniaux E, Burton GJ. The effect of smoking in pregnancy on early placental morphology. Obstet Gynecol 1992 79 : 645 8.